Drug
Centanafadine clinical trials
Also written EB-1020.
Includes 2 studies of Centanafadine hydrochloride.
- studies test it
- 25
- open now
- 5
- in phase 3
- 12
- first study started
- 2013
Keep track of what changes. Save the centanafadine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
25 studies that test it; most in 2022 (5)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 6
- Phase 3
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 0
Otsuka Pharmaceutical Development & Commercialization, Inc. (21) · Otsuka Pharmaceutical Co., Ltd. (4)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses centanafadine is read from its arms, and is right about nine times in ten.
Testing it · 25
- A Long-term Trial of EB-1020 in Adult Patients With ADHDRecruitingPhase 3Otsuka Pharmaceutical Co., Ltd.NCT06926829Written as EB-1020 (Centanafadine) 164.4 mg
- Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD PatientsRecruitingPhase 2/3Otsuka Pharmaceutical Co., Ltd.NCT06931080Written as EB-1020 (Centanafadine) 164.4 mg
- A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional DysregulationRecruitingPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07759154Written as Centanafadine XR
- A Long-term Trial of EB-1020 in Pediatric Patients With ADHDRecruitingPhase 3Otsuka Pharmaceutical Co., Ltd.NCT07087327Written as EB-1020 (Centanafadine) low dose
- A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHDRecruitingPhase 2/3Otsuka Pharmaceutical Co., Ltd.NCT07086313Written as EB-1020 (Centanafadine) low dose
- A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.CompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05279313Written as Centanafadine Hydrochloride
- Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive DisorderCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05536414Written as Centanafadine
- P3b Short-term Study of CTN in Patients With ADHD and Comorbid AnxietyCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06973577Written as Centanafadine
- A Trial to Assess How Centanafadine Interacts With Stimulants in the BodyCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07314333Written as Centanafadine
- A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020CompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT01744808Written as EB-1020 IR
- A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant UsersCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT02144415Written as EB-1020 400 mg
- A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)CompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05428033Written as centanafadine capsule
- Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy SubjectsCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07486895Written as Centanafadine
- A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of CentanafadineCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07465731Written as Centanafadine SR
- A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood LevelsCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07253441Written as CTN XR (TBM)
- A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating DisorderCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05113953Written as Centanafadine
- Efficacy of Centanafadine SR as a Potential Smoking Cessation TreatmentCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05066724Written as Centanafadine
- A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity DisorderCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03605849Written as Centanafadine SR
- A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity DisorderCompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05257265Written as Centanafadine Hydrochloride
- A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity DisorderCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04786730Written as Centanafadine
Codes
What other systems call centanafadine · ClinicalTrials.gg INT006113
- UNII (FDA) D2A6T4UH9CCENTANAFADINEConfirmed FDA, Wikidata
- Wikidata Q27276010centanafadineConfirmed FDA, Wikidata
- NCI Thesaurus C171666CentanafadineOne source FDA
- DrugBank DB14841One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | D2A6T4UH9C | CENTANAFADINE | Confirmed FDA, Wikidata |
| Wikidata | Q27276010 | centanafadine | Confirmed FDA, Wikidata |
| NCI Thesaurus | C171666 | Centanafadine | One source FDA |
| DrugBank | DB14841 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.